Skip to main content
Archived articles

immunotherapy

grey balls on a larger orange ball-shaped object
Cancer research
FDA approves cancer drug for personalized immunotherapy approach
Published Sept 20, 2017
Drug was developed from 30 years of basic research at Johns Hopkins
Cancer research
Immune to immunotherapy
Published Sept 20, 2017
Johns Hopkins scientists zero in on process that helps cancer cells evade immune system attacks during immunotherapy treatment
Cancer research
A landmark year for immunotherapy
Published Sept 20, 2017
Bloomberg–Kimmel Institute for Cancer Immunotherapy director recaps five major research findings from 2016
Cancer research
How immunotherapy works
Published Sept 20, 2017
Treatment is like releasing the immune system's 'parking brake,' JHU oncologist Drew Pardoll says / The Washington Post
Cancer research
A personalized approach for immunotherapy
Published Sept 20, 2017
Collaboration with Bristol-Myers Squibb includes several clinical trials led by scientists at Bloomberg-Kimmel Institute
Cancer research
A chemotherapy alternative
Published Sept 20, 2017
Immunotherapy deploys the body's natural ability to fight cancer, could reduce toxic chemo treatments for children / Promise & Progress
Bacteria and cancer risk
Published Sept 20, 2017
Normal bacterial colonies in human body linked to presence of mouth and throat cancer / Hopkins Medicine
Microscopic look at Merkel cancer tumor cells
Cancer research
Promising new drug for virus-linked skin cancer
Published Sept 20, 2017
Immunotherapy drug shrinks tumors in half of patients with Merkel cell carcinoma / Hopkins Medicine